Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics

Core Insights - Analysts project Insmed (INSM) will report a quarterly loss of -$1.32 per share, a decline of 3.9% year over year, with revenues expected to reach $114.65 million, an increase of 22.7% from the same quarter last year [1] Earnings Projections - The consensus EPS estimate for the quarter has been revised downward by 0.6% over the past 30 days, indicating a collective reassessment by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Estimates - Analysts estimate 'Revenue- Japan' at $29.88 million, reflecting a year-over-year increase of 42.4% [5] - The 'Revenue- Europe and rest of world' is projected at $7.24 million, indicating a 29.8% year-over-year change [5] - 'Revenue- U.S.' is expected to reach $72.72 million, showing an 8.8% increase year over year [5] Stock Performance - Insmed shares have returned +14.8% over the past month, outperforming the Zacks S&P 500 composite, which saw a +3.8% change [5] - With a Zacks Rank 3 (Hold), Insmed is anticipated to reflect overall market performance in the near future [5]